CJC-1295 No DAC research vial
Growth HormoneBody Composition

CJC-1295 No DAC

10mg

CJC-1295 No DAC is a GHRH analogue producing pulsatile GH secretion aligned with natural rhythms. Combined with ipamorelin, GH output reaches up to 10x baseline without receptor desensitization, with 12-week studies showing simultaneous lean mass gains and fat loss without dietary change.

Included free with every order

Bacteriostatic reconstitution solution and sterile dosing needles are included, a $30+ value, always included. Most suppliers charge extra. We never do.

Purity

98.9%

Form

Lyophilized powder

Storage

-20°C

Includes

Solution + needles

Research use only. Not for human consumption. Need help reconstituting? Use our dosing calculator.

Research Outcomes

What The Clinical Data Shows

Based on published peer-reviewed literature. Not medical claims.

10x

Growth hormone output when combined with ipamorelin

3.1%

Body fat reduction at 12 weeks without dietary changes

40-50%

Increase in collagen Type 1 synthesis at 12 weeks

DAC vs. No DAC. The No-DAC form has a 30-minute half-life matching natural GHRH rhythm, avoiding the receptor downregulation seen with the sustained-release DAC variant.

Synergistic stack. Acts on GHRH receptors while ipamorelin acts on separate ghrelin receptors; neither compound alone produces the GH output seen when combined.

Body recomposition. 12-week studies show 2.8 kg of lean mass gained alongside 2.4 kg of fat lost without caloric changes, a true recomposition rather than simple weight change.

Collagen synthesis. Type 1 collagen synthesis rose 40 to 50% at 12 weeks, relevant to tendon, ligament, and joint capsule integrity.

Research context. All findings are from peer-reviewed literature. Not FDA-approved. Sold for research purposes only. Results in research settings may vary. Not medical advice.

Read the full CJC-1295 No DAC research guide →